IL22 and psoriasis: Psoriasis is considered to be a T cell-mediated disease, whereby a mix of Th1 and Th17 T cell-derived cytokines, such as IFNγ, IL17A and IL22, drive the pathological hyperproliferation, aberrant differentiation and the autoimmune amplification of keratinocytes that ultimately drive psoriatic plaque formation.